Request for Information on the Development of the Fiscal Year 2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health Research, 68179-68180 [2019-26915]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices
in place for 6 months after the
conclusion on the workshop or Summit.
Healthy Aging Workshops and Summit
Opportunity A—Healthy Aging
Regional Workshops will involve
executing a single or series of
financially self-sustaining workshops
that convene aging and public health
stakeholders to support regional action
planning and dissemination of
information on healthy aging, aging in
place, and age-friendly public health
systems. ODPHP plans to hold four
workshops. Each workshop will be held
in a city located in one of the designated
HHS Regional pairs—Regions 3 & 4
(Atlanta), Regions 6 & 9 (Phoenix or
Albuquerque), Regions 5 & 7 (Kansas
City or Chicago), and Regions 8 & 10
(Denver).
Opportunity B—2021 Healthy Aging
Summit—The collaborative project will
involve executing a single financially
self-sustaining conference that supports
research and information-sharing on
health promotion and disease
prevention research across the lifespan.
This conference draws more than 600
stakeholders, every three years, to
examine the state of the science and best
practices in healthy aging through a
social determinants of health lens. Past
conference information can be found
here: https://www.eventscribe.com/
2018/ACPM-HAC/index.asp?
launcher=1.
jbell on DSKJLSW7X2PROD with NOTICES
Eligibility for Co-Sponsorships
To be eligible, a collaborating
organization shall: (1) Have a
demonstrated interest in, understanding
of, and experience with managing the
development and execution of engaging
programs, activations and/or other
activities related to disease prevention
and health promotion; (2) participate
substantively in the co-sponsored
activity (not only logistical support)
including helping plan the 2020 Healthy
Aging Regional workshops and/or 2021
Healthy Aging Summit; (3) have an
organizational or corporate mission that
is aligned with the mission of ODPHP
and HHS; and (4) sign a co-sponsorship
agreement with ODPHP that will set
forth the details of the Healthy Aging
Regional Workshop and/or Summit,
including the requirements that any
registration fees raised should not
exceed the collaborating organization’s
costs, and fees collected by the cosponsor should be limited to the amount
necessary to cover the co-sponsor’s
event-related operating expenses. Cosponsors are solely responsible for
collecting and handling any fees to
cover their costs.
VerDate Sep<11>2014
17:42 Dec 12, 2019
Jkt 250001
The co-sponsor will furnish the
necessary personnel, materials, services,
and facilities to administer its
responsibility for the proposed Healthy
Aging Regional Workshops and/or
Summit. These duties will be
determined and outlined in a cosponsorship agreement with ODPHP.
This co-sponsorship agreement does not
represent an endorsement by ODPHP of
an individual co-sponsor’s policies,
positions, or activities.
Co-Sponsorship Proposal
Each potential co-sponsor’s proposal
shall contain a description of:
(1) The entity or organization’s
interest and goals in healthy aging;
(2) Prior experience and current
readiness to undertake the
responsibilities for planning and
organizing a Healthy Aging Regional
workshop(s) and/or Summit;
(3) Requester’s information: Name,
professional qualifications and specific
expertise of key personnel who would
be available to work on the project;
(4) The type of event(s), i.e.,
Workshop or 2021 Summit, that the
entity is interested in co-sponsoring
with ODPHP;
(5) Facilities available for the event(s);
(6) Description of financial
management: Discussion of experience
in developing a project budget and
collecting and managing monies from
organizations and individuals;
(7) For the Healthy Aging Summit
only: Proposed plan for managing
Summit, including, but not limited to
participant recruitment, call for
abstracts distribution/review, ability to
provide CEs, website development and/
or enhancement, cost of materials, and
distribution of those items.
Proposals should be no more than
four (4) pages, 12 point font, double
spaced.
Dated: November 29, 2019.
Donald Wright,
Deputy Assistant Secretary for Health,
Disease Prevention and Health Promotion.
[FR Doc. 2019–26821 Filed 12–12–19; 8:45 am]
BILLING CODE 4150–32–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on the
Development of the Fiscal Year 2021–
2025 Trans-NIH Strategic Plan for
Sexual & Gender Minority Health
Research
AGENCY:
National Institutes of Health,
HHS.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
ACTION:
68179
Notice.
Through this Request for
Information (RFI), the Sexual & Gender
Minority Research Office (SGMRO) in
the Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI), Office of the Director (OD),
National Institutes of Health (NIH),
invites feedback from stakeholders
throughout the scientific research
community, clinical practice
communities, patient and family
advocates, scientific or professional
organizations, federal partners, internal
NIH stakeholders, and other interested
constituents on the development of the
fiscal years (FY) 2021–2025 Trans-NIH
Strategic Plan for Sexual and Gender
Minority Health Research. This plan
will describe future directions in sexual
and gender minority (SGM) health and
research to optimize NIH’s research
investments.
DATES: The SGMRO’s Request for
Information is open for public comment
for a period of 6 weeks. Comments must
be received on or before COB (5:00 p.m.
ET) January 24, 2020 to ensure
consideration. After the public comment
period has closed, the comments
received by SGMRO will be considered
in a timely manner for the development
of the FY 2021–2025 Trans-NIH
Strategic Plan for SGM Health Research.
ADDRESSES: Please see the
supplementary information to view the
draft scientific and operational goals.
Comments are strongly encouraged to be
submitted by email to SGMRO@nih.gov
or by mail to: SGMRO, DPCPSI, NIH,
6555 Rock Spring Drive, Suite 220, Rm.
2SE31J, Bethesda, MD 20817. Please
include strategic plan in the subject
line.
FOR FURTHER INFORMATION CONTACT:
Karen Parker, Ph.D., MSW, Director,
Sexual & Gender Minority Research
Office (SGMRO), 6555 Rock Spring
Drive, Suite 220, Rm 2SE31K, Bethesda,
MD 20817, klparker@mail.nih.gov, 301–
451–2055.
SUPPLEMENTARY INFORMATION:
Background: ‘‘Sexual and gender
minority’’ is an umbrella term that
includes, but is not limited to,
individuals who identify as lesbian, gay,
bisexual, asexual, transgender, twospirit, queer, and/or intersex.
Individuals with same-sex or -gender
attractions or behaviors and those with
a difference in sex development are also
included. These populations also
encompass those who do not selfidentify with one of these terms but
whose sexual orientation, gender
identity or expression, or reproductive
development is characterized by nonSUMMARY:
E:\FR\FM\13DEN1.SGM
13DEN1
jbell on DSKJLSW7X2PROD with NOTICES
68180
Federal Register / Vol. 84, No. 240 / Friday, December 13, 2019 / Notices
binary constructs of sexual orientation,
gender, and/or sex.
The Sexual and Gender Minority
Research Office (SGMRO) coordinates
sexual and gender minority (SGM)related research and activities by
working directly with the NIH
Institutes, Centers, and Offices. The
Office was officially established in
September 2015 within the NIH
Division of Program Coordination,
Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
In accordance with the 21st Century
Cures Act, NIH is required to regularly
update their strategic plans. In 2015, the
NIH launched the NIH FY 2016–2020
Strategic Plan to Advance Research on
the Health and Well-being of Sexual and
Gender Minorities. The current strategic
plan has provided the NIH with a
framework to improve the health of
SGM populations through increased
research and support of scientists
conducting SGM-relevant research. In
January 2019, SGMRO published a midcourse review of the current NIH SGM
strategic plan that provided
recommendations to support further
progress on the goals described therein.
To establish NIH priorities in SGM
health research for the next five years,
SGMRO requests input from SGM
health, research, and related
communities in refining the goals of the
FY 2021–2025 strategic plan.
Request for Comment on Draft Goals:
The NIH is developing a strategic plan
to advance SGM research over the next
five years. The SGMRO invites input
from stakeholders throughout the
scientific research community, clinical
practice communities, patient and
family advocates, scientific or
professional organizations, federal
partners, internal NIH stakeholders, and
other interested members of the public
on the proposed framework. This input
is a valuable component in developing
the SGM research strategic plan, and the
community’s time and consideration are
appreciated.
The populations considered under the
SGM umbrella term are inclusive and
captures all individuals and populations
who do not self-identify with binary
constructs of sexual orientation, gender,
and/or sex. For the FY 2021–2025
strategic plan, the scientific goals will
include a focus on specific populations
on which the lack of research remains
significant. Examples of such
populations may include persons with
differences in sex development (DSD),
intersex, bisexual, transgender, gender
nonconforming, persons who have
detransitioned/desisted people, and
SGM populations in Native
communities.
VerDate Sep<11>2014
17:42 Dec 12, 2019
Jkt 250001
In addition, overarching topics will be
considered across all scientific research
goal areas in order to help foster a
deeper understanding of SGM health
disparities. Topics to be considered
include health equity, research across
the life span, trauma-informed research,
community and culturally grounded
research, and strengths-based
approaches. Scientific goal areas will
also take into consideration
intersectionality by recognizing
overlapping and interconnected systems
of oppression across different social
categories and how they may compound
health inequities. Examples of such
categories may include ability status,
age, race, ethnicity, incarceration status,
veteran status, income level, and more.
The NIH has identified four scientific
research goal areas:
• Clinical Research: Examples
include outcomes related to various
DSDs, and sexual reproduction and
pregnancy outcomes
• Social & Behavioral Research:
Examples include the coming out
process, healthy sexuality, interpersonal
violence, mental health, substance use
and abuse (opioids, tobacco use, other
drugs), suicide risk and prevention, and
stigma and discrimination
• Chronic Diseases and Comorbidities
Research: Examples include
Alzheimer’s Disease and Related
Dementias (ADRD), cancer, diabetes,
heart disease, HIV/AIDS, and infectious
diseases
• Methods and Measures Research:
Examples include culturally humble
psychometrics, research on recruitment
and sampling methods, particularly for
most understudied SGM subgroups, and
factors related to disclosure on surveys
The NIH has also identified four
operational goal areas:
• Advance rigorous research on the
health of SGM populations in both the
extramural and intramural research
communities
• Expand SGM health research by
fostering partnerships and
collaborations with a strategic array of
internal and external stakeholders
• Foster a highly skilled and diverse
workforce in the SGM health research
• Encourage data collection related to
SGM populations in research and in the
biomedical research workforce
The NIH seeks comments and/or
suggestions from all interested parties
on the proposed strategic plan goals.
Responses to this RFI are voluntary.
Do not include any proprietary,
classified, confidential, trade secret, or
sensitive information in your response.
The responses will be reviewed by NIH
staff, and individual feedback will not
be provided to any responder. The
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
Government will use the information
submitted in response to this RFI at its
discretion. The Government reserves the
right to use any submitted information
on public NIH websites; in reports; in
summaries of the state of the science; in
any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or
in the development of future funding
opportunity announcements.
This RFI is for information and
planning purposes only and should not
be construed as a solicitation for
applications or proposals, or as an
obligation in any way on the part of the
United States Federal Government, the
NIH, or individual NIH Institutes,
Centers, and Offices to provide support
for any ideas identified in response to
it. The Federal Government will not pay
for the preparation of any information
submitted or for the Government’s use
of such information. No basis for claims
against the U.S. Government shall arise
as a result of a response to this RFI or
from the Government’s use of such
information. Additionally, the
Government cannot guarantee the
confidentiality of the information
provided.
Dated: December 6, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes
of Health.
[FR Doc. 2019–26915 Filed 12–12–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
[1651–0098]
Agency Information Collection
Activities: NAFTA Regulations and
Certificate of Origin
U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 60-Day notice and request for
comments; extension of an existing
collection of information.
AGENCY:
The Department of Homeland
Security, U.S. Customs and Border
Protection will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995 (PRA). The
information collection is published in
the Federal Register to obtain comments
from the public and affected agencies.
Comments are encouraged and must be
SUMMARY:
E:\FR\FM\13DEN1.SGM
13DEN1
]]>Agencies
[Federal Register Volume 84, Number 240 (Friday, December 13, 2019)]
[Notices]
[Pages 68179-68180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-26915]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Request for Information on the Development of the Fiscal Year
2021-2025 Trans-NIH Strategic Plan for Sexual & Gender Minority Health
Research
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Through this Request for Information (RFI), the Sexual &
Gender Minority Research Office (SGMRO) in the Division of Program
Coordination, Planning, and Strategic Initiatives (DPCPSI), Office of
the Director (OD), National Institutes of Health (NIH), invites
feedback from stakeholders throughout the scientific research
community, clinical practice communities, patient and family advocates,
scientific or professional organizations, federal partners, internal
NIH stakeholders, and other interested constituents on the development
of the fiscal years (FY) 2021-2025 Trans-NIH Strategic Plan for Sexual
and Gender Minority Health Research. This plan will describe future
directions in sexual and gender minority (SGM) health and research to
optimize NIH's research investments.
DATES: The SGMRO's Request for Information is open for public comment
for a period of 6 weeks. Comments must be received on or before COB
(5:00 p.m. ET) January 24, 2020 to ensure consideration. After the
public comment period has closed, the comments received by SGMRO will
be considered in a timely manner for the development of the FY 2021-
2025 Trans-NIH Strategic Plan for SGM Health Research.
ADDRESSES: Please see the supplementary information to view the draft
scientific and operational goals. Comments are strongly encouraged to
be submitted by email to [email protected] or by mail to: SGMRO, DPCPSI,
NIH, 6555 Rock Spring Drive, Suite 220, Rm. 2SE31J, Bethesda, MD 20817.
Please include strategic plan in the subject line.
FOR FURTHER INFORMATION CONTACT: Karen Parker, Ph.D., MSW, Director,
Sexual & Gender Minority Research Office (SGMRO), 6555 Rock Spring
Drive, Suite 220, Rm 2SE31K, Bethesda, MD 20817, [email protected],
301-451-2055.
SUPPLEMENTARY INFORMATION:
Background: ``Sexual and gender minority'' is an umbrella term that
includes, but is not limited to, individuals who identify as lesbian,
gay, bisexual, asexual, transgender, two-spirit, queer, and/or
intersex. Individuals with same-sex or -gender attractions or behaviors
and those with a difference in sex development are also included. These
populations also encompass those who do not self-identify with one of
these terms but whose sexual orientation, gender identity or
expression, or reproductive development is characterized by non-
[[Page 68180]]
binary constructs of sexual orientation, gender, and/or sex.
The Sexual and Gender Minority Research Office (SGMRO) coordinates
sexual and gender minority (SGM)-related research and activities by
working directly with the NIH Institutes, Centers, and Offices. The
Office was officially established in September 2015 within the NIH
Division of Program Coordination, Planning, and Strategic Initiatives
(DPCPSI) in the Office of the Director.
In accordance with the 21st Century Cures Act, NIH is required to
regularly update their strategic plans. In 2015, the NIH launched the
NIH FY 2016-2020 Strategic Plan to Advance Research on the Health and
Well-being of Sexual and Gender Minorities. The current strategic plan
has provided the NIH with a framework to improve the health of SGM
populations through increased research and support of scientists
conducting SGM-relevant research. In January 2019, SGMRO published a
mid-course review of the current NIH SGM strategic plan that provided
recommendations to support further progress on the goals described
therein. To establish NIH priorities in SGM health research for the
next five years, SGMRO requests input from SGM health, research, and
related communities in refining the goals of the FY 2021-2025 strategic
plan.
Request for Comment on Draft Goals: The NIH is developing a
strategic plan to advance SGM research over the next five years. The
SGMRO invites input from stakeholders throughout the scientific
research community, clinical practice communities, patient and family
advocates, scientific or professional organizations, federal partners,
internal NIH stakeholders, and other interested members of the public
on the proposed framework. This input is a valuable component in
developing the SGM research strategic plan, and the community's time
and consideration are appreciated.
The populations considered under the SGM umbrella term are
inclusive and captures all individuals and populations who do not self-
identify with binary constructs of sexual orientation, gender, and/or
sex. For the FY 2021-2025 strategic plan, the scientific goals will
include a focus on specific populations on which the lack of research
remains significant. Examples of such populations may include persons
with differences in sex development (DSD), intersex, bisexual,
transgender, gender nonconforming, persons who have detransitioned/
desisted people, and SGM populations in Native communities.
In addition, overarching topics will be considered across all
scientific research goal areas in order to help foster a deeper
understanding of SGM health disparities. Topics to be considered
include health equity, research across the life span, trauma-informed
research, community and culturally grounded research, and strengths-
based approaches. Scientific goal areas will also take into
consideration intersectionality by recognizing overlapping and
interconnected systems of oppression across different social categories
and how they may compound health inequities. Examples of such
categories may include ability status, age, race, ethnicity,
incarceration status, veteran status, income level, and more.
The NIH has identified four scientific research goal areas:
Clinical Research: Examples include outcomes related to
various DSDs, and sexual reproduction and pregnancy outcomes
Social & Behavioral Research: Examples include the coming
out process, healthy sexuality, interpersonal violence, mental health,
substance use and abuse (opioids, tobacco use, other drugs), suicide
risk and prevention, and stigma and discrimination
Chronic Diseases and Comorbidities Research: Examples
include Alzheimer's Disease and Related Dementias (ADRD), cancer,
diabetes, heart disease, HIV/AIDS, and infectious diseases
Methods and Measures Research: Examples include culturally
humble psychometrics, research on recruitment and sampling methods,
particularly for most understudied SGM subgroups, and factors related
to disclosure on surveys
The NIH has also identified four operational goal areas:
Advance rigorous research on the health of SGM populations
in both the extramural and intramural research communities
Expand SGM health research by fostering partnerships and
collaborations with a strategic array of internal and external
stakeholders
Foster a highly skilled and diverse workforce in the SGM
health research
Encourage data collection related to SGM populations in
research and in the biomedical research workforce
The NIH seeks comments and/or suggestions from all interested
parties on the proposed strategic plan goals.
Responses to this RFI are voluntary. Do not include any
proprietary, classified, confidential, trade secret, or sensitive
information in your response. The responses will be reviewed by NIH
staff, and individual feedback will not be provided to any responder.
The Government will use the information submitted in response to this
RFI at its discretion. The Government reserves the right to use any
submitted information on public NIH websites; in reports; in summaries
of the state of the science; in any possible resultant solicitation(s),
grant(s), or cooperative agreement(s); or in the development of future
funding opportunity announcements.
This RFI is for information and planning purposes only and should
not be construed as a solicitation for applications or proposals, or as
an obligation in any way on the part of the United States Federal
Government, the NIH, or individual NIH Institutes, Centers, and Offices
to provide support for any ideas identified in response to it. The
Federal Government will not pay for the preparation of any information
submitted or for the Government's use of such information. No basis for
claims against the U.S. Government shall arise as a result of a
response to this RFI or from the Government's use of such information.
Additionally, the Government cannot guarantee the confidentiality of
the information provided.
Dated: December 6, 2019.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2019-26915 Filed 12-12-19; 8:45 am]
BILLING CODE 4140-01-P
